BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile
..
 

Theraclone Sciences, Inc. 

Seattle Life Sciences Building
1124 Columbia Street, Suite 300
Seattle  Washington  98104  U.S.A.
Phone: 206-805-1600 Fax: 206-805-1699


SEARCH JOBS


Industry
Biotechnology

Segment
Life Sciences





 Company News
PharmAthene, Inc. (PIP) Terminates Merger Agreement With Theraclone Sciences, Inc. 12/2/2013 8:43:17 AM    More...
Theraclone Sciences, Inc. Gets Bad News From Biomedical Advanced Research and Development Authority (BARDA) Regarding Pandemic Flu Drug 11/27/2013 7:44:03 AM    More...
Theraclone Sciences, Inc. Presents Positive Data from Phase 1 Trial of Therapeutic Antibody for the Treatment of Human Cytomegalovirus Infection at ICAAC 2013 9/11/2013 9:46:14 AM    More...
Theraclone Sciences, Inc. Announces Initiation of Phase 2a Trial of TCN-202 for the Prevention of Human Cytomegalovirus Infection 9/10/2013 9:36:06 AM    More...
Theraclone Sciences, Inc. Announces Universal Therapeutic Antibody for Influenza A Demonstrates Reductions in Clinical Symptoms Score and Viral Load in a Phase 2a Human Viral Challenge Study 9/9/2013 10:33:38 AM    More...
Few Redundancies' Between PharmAthene, Inc. (PIP) and Theraclone Sciences, Inc. Means No Layoffs 8/6/2013 8:10:48 AM    More...
PharmAthene, Inc. (PIP) and Theraclone Sciences, Inc. Announce Merger Agreement to Create Diversified Biologics Company Targeting Government and Commercial Markets 8/1/2013 9:48:49 AM    More...
Theraclone Sciences, Inc. Announces Positive Top-Line Data From Phase 1 Trial of Therapeutic Antibody for the Treatment of Human Cytomegalovirus Infection 4/2/2013 9:44:11 AM    More...
Theraclone Sciences, Inc. Secures $14 Million 3/25/2013 7:53:29 AM    More...
Theraclone Sciences, Inc. Initiates Phase 2 Viral Challenge Clinical Study of Therapeutic Antibody for the Treatment of Influenza A 10/25/2012 9:51:57 AM    More...
123

//-->